WHO ICTRP trial
A study of 177 lutetium dotatate in children with primary refractory or relapsed…
ISRCTN98918118 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN98918118 |
|---|---|
| Public title | A study of 177 lutetium dotatate in children with primary refractory or relapsed high-risk neuroblastoma |
| Scientific title | A Phase IIa trial of 177 177 lutetium dotatate in children with primary refractory or relapsed high-risk neuroblastoma |
| Primary sponsor | University of Birmingham (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United Kingdom |
| Conditions | Topic: National Cancer Research Network; Subtopic: Paediatric Oncology; Disease: Brain and Nervous System Cancer |
| Interventions | 177Lutetium DOTATATE: The investigational medicinal product (IMP) for the study. Patients will receive up to a maximum of 4 administrations 8 weeks apart. 68Ga DOTATATE PET/CT: Potential patients for this study will require a 68Ga DOTATATE… |
| Registration date | Dec 20, 2013 |
| Target size | 24 |
| Secondary IDs | 2012-000510-10;13254 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: